(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose ...
(Reuters) -Eli Lilly raised its annual revenue forecast by $2 billion on Tuesday due to strong demand and plans to increase ...
Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise ...
INDIANAPOLIS (dpa-AFX) - Eli Lilly And Co. (LLY) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates. The company's earnings totaled ...
14.05.24 S&P 500-Titel Eli Lilly and-Aktie: So viel Gewinn hätte eine Investition in Eli Lilly and von vor 5 Jahren abgeworfen 30.04.24 S&P 500-Wert Eli Lilly and-Aktie: So viel Gewinn hätte ein ...
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment ...
(RTTNews) - Eli Lilly And Co. (LLY) revealed earnings for its first quarter that increased from the same period last year and ...
(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly (NYSE: LLY )'s weight-loss drug Zepbound drove the ...